Therefore, it remains unclear whether P-gp overexpression in the epileptogenic brain tissue of patients with pharmacoresistant epilepsy is the cause or consequence of drug-resistant epilepsy, uncontrolled seizures, chronic ASM treatment, or a combination of these factors [72]. Here, PGP is linked to epilepsy.